Eriberto Noel Natali

Dec 8, 2024 | nature.com | Eriberto Noel Natali |Patrick Meier |Victor Greiff |Mario Nuvolone |Katja Fink

Correction to: npj Vaccines https://doi.org/10.1038/s41541-023-00788-7, published online 20 January 2024In the original version of this Article, the code availability conditions were not clear in the Methods section. The article has now been corrected to clarify that research requests for access to the code need to be approved by the code owners.

Feb 12, 2024 | nature.com | Eriberto Noel Natali |Patrick Meier |Victor Greiff |Mario Nuvolone |Katja Fink

Correction to: npj Vaccines https://doi.org/10.1038/s41541-023-00788-7, published online 20 January 2024In this article, the affiliation details for author Alexander Horst were incorrectly given as Alexander Horst1,2 but should have been Alexander Horst1 and other affiliations are renumbered. The original article has been corrected.

Jan 19, 2024 | nature.com | Patrick Meier |Victor Greiff |Mario Nuvolone |Katja Fink |Eriberto Noel Natali

AbstractDengue virus poses a serious threat to global health and there is no specific therapeutic for it. Broadly neutralizing antibodies recognizing all serotypes may be an effective treatment. High-throughput adaptive immune receptor repertoire sequencing (AIRR-seq) and bioinformatic analysis enable in-depth understanding of the B-cell immune response.